PMID: 6976407Dec 1, 1981Paper

Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens

The Journal of Experimental Medicine
A AlbinoL J Old

Abstract

Three established lines of melanoma cells were derived from anatomically distinct metastases occurring in a single patient (DX). The lines, DX-1, DX-2, and DX-3, showed marked phenotypic diversity, as indicated by characteristic differences in growth rate, morphology, pigmentation, and the expression of surface antigens and glycoproteins. DX-1 and DX-3 expressed HLA-DR products, whereas DX-2 lacked HLA-DR expression. DX-1, DX-2, and DX-3 could also be distinguished on the basis of the profile of radiolabeled glycoproteins. Additional quantitative differences in the surface antigenic phenotype of the three cell lines were revealed by serological tests with a battery of monoclonal and conventional antibodies defining melanoma differentiation antigens. In tests for autologous humoral immunity to melanoma cells, sera from patient DX were found to have IgG antibody that reacted with surface antigens of DX-2 cells; no autologous reactivity was seen with DX-1 or DX-3 target cells or with three more recently established melanoma cell lines from patient DX. Absorption analysis indicated that the antigen detected by DX sera on DX-2 cells is a class 1 melanoma antigen, having been detected only on DX-2 cells and in much lower but demonstr...Continue Reading

References

Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·H KoprowskiM Herlyn
Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·T J GarrettL J Old
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M PfreundschuhL J Old
Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·T E CareyL J Old
Mar 1, 1979·The Journal of Experimental Medicine·B S WilsonS Ferrone
Sep 19, 1979·The Journal of Experimental Medicine·R UedaL J Old
Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·T E CareyL J Old
Jul 1, 1974·European Journal of Biochemistry·W M Bonner, R A Laskey
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A N HoughtonL J Old
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·W G DippoldL J Old
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R UedaL J Old

❮ Previous
Next ❯

Citations

Jan 1, 1983·Cancer Metastasis Reviews·G H Heppner, B E Miller
Jan 1, 1983·Cancer Metastasis Reviews·J E Talmadge
Jun 1, 1991·Cancer Metastasis Reviews·S A LynchA N Houghton
Jan 1, 1987·Clinical & Experimental Metastasis·S S JoshiK W Brunson
Oct 1, 1987·Clinical & Experimental Metastasis·P L LolliniP Nanni
Jan 1, 1982·Cancer Metastasis Reviews·F R Miller
Mar 1, 1995·World Journal of Surgery·M Gutman, I J Fidler
Jan 1, 1987·Archives of Dermatological Research·A KohchiyamaH Ueki
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·J L Abbruzzese, P Frost
Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·D H SchulzeS G Nathenson
Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R J CoteL J Old
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A KnuthL J Old
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·N C DracopoliL J Old
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A S Blum, C J Barnstable
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·H YamaguchiL J Old
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·F X RealK O Lloyd
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·P D SenterK E Hellström
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C D EstinK E Hellström
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A KnuthK H Meyer zum Büschenfelde
Dec 1, 1982·The Journal of Experimental Medicine·A N HoughtonL J Old
Mar 1, 1987·The Journal of Experimental Medicine·A N HoughtonL J Old
Jun 1, 1988·The Journal of Experimental Medicine·R L WeinshankJ V Ravetch
Jan 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·R K SinghR Radinsky
Oct 1, 1982·Journal of Clinical Pathology·R L Carter
Sep 2, 2010·PloS One·Vladislava O MelnikovaMenashe Bar-Eli
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·S D SharmaV J Hruby
Nov 27, 1982·Lancet·A Berken
Jan 1, 1985·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·E K Rofstad, T Brustad
Jul 1, 1986·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·E K Rofstad, T Brustad
Jan 1, 1992·Cancer Investigation·A E Chang, S Shu
Feb 11, 1991·American Journal of Obstetrics and Gynecology·S C RubinJ L Lewis
Apr 28, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tracy A Denison, You Han Bae
Nov 19, 2004·Neoplasia : an International Journal for Oncology Research·Edwin BremerWijnand Helfrich
Sep 27, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Qi YangSamuel K Lai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.